FDA Food and Drug Administration

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday. The oral drug, branded Symbravo, was approved for the acute treatment of the condition characterized by recurrent attacks of moderate to severe throbbing and pulsating pain on one side of the head.

The Hill · 3h

FDA approves new type of non-opioid pain medication

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is

ABC · 5h

FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.

MLive4h

This chocolate recall has been upgraded to FDA’s highest risk level

STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...

WISH-TV on MSN6h

FDA redefines ‘healthy’ food labels to help consumers make informed choices

The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...

Opinion

Havasu News46mOpinion

Chicago Tribune: Not all ‘processed’ food is bad — but Red Dye No. 3 doesn’t belong in what we eat

Last week, the Food and Drug Administration banned Red Dye No. 3 over cancer risks. Good.

PBS5d

The FDA banned Red 3 food coloring. A scientist explains the dye’s history and health risks

Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.

8hOpinion

Do food warning labels actually work? Answering your questions.

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

Hosted on MSN2h

Celltrion gets U.S. FDA approval for new biosimilar for autoimmune disease treatment

Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA).

Results that may be inaccessible to you are currently showing.

Hide inaccessible results